Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Qiagen NV (NASDAQ:QGEN)

31.67
Delayed Data
As of Dec 12
 +0.41 / +1.31%
Today’s Change
27.38
Today|||52-Week Range
36.34
+13.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$7.2B

Company Description

QIAGEN NV is a holding company, which engages in the manufacture and distribution of sample and assay technology products for preanalytical sample preparations. It provides solutions to customers that are classified into molecular diagnostics, applied testing, pharma, and academia. Its products include instruments, and consumables and related products. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Contact Information

QIAGEN NV
Hulsterweg 82
Venlo Limburg 5912 PL
P:(177) 355-6600
Investor Relations:

Employees

Shareholders

Mutual fund holders47.71%
Other institutional20.31%
Individual stakeholders--

Top Executives

Peer Michael SchatzChief Executive Officer
Douglas LiuSenior Vice President-Global Operations
Manuel O. MendezSenior Vice President-Global Commercial Operations
Roland SackersChief Financial Officer
Bradford J. CrutchfieldSenior VP-Life Sciences Business Area